Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | ATEA PHARMACEUTICALS INC AVIR | RA Capital Management, L.P. | 0 0.000% | -5,368,451 (Position Closed) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | OTONOMY INC OTIC | RA Capital Management, L.P. | 5,600,000 9.900% | 2,507,706 (+81.10%) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | SERES THERAPEUTICS INC MCRB | RA Capital Management, L.P. | 0 0.000% | -235,110 (Position Closed) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | MACROGENICS INC MGNX | RA Capital Management, L.P. | 6,103,594 9.960% | 1,728,377 (+39.50%) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | RA Capital Management, L.P. | 3,115,008 9.900% | -710,000 (-18.56%) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA Capital Management, L.P. | 7,567,900 13.300% | 1,702,562 (+29.03%) | Filing History |
| 2022-02-14 4:11 pm Unchanged | 2021-12-31 | 13G | OLEMA PHARMACEUTICALS INC OLMA | RA Capital Management, L.P. | 2,150,404 5.300% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | ZOGENIX INC ZGNX | RA Capital Management, L.P. | 3,333,700 6.000% | -2,011,931 (-37.64%) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | ASTRIA THERAPEUTICS INC ATXS | RA Capital Management, L.P. | 1,262,193 9.700% | -4,483,551 (-78.03%) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | NAUTILUS BIOTECHNOLOGY INC NAUT | RA Capital Management, L.P. | 2,436,430 2.000% | 1,436,430 (+143.64%) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | CYTOMX THERAPEUTICS INC CTMX | RA Capital Management, L.P. | 0 0.000% | -3,500,000 (Position Closed) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | TANGO THERAPEUTICS INC TNGX | RA Capital Management, L.P. | 2,250,000 2.600% | 1,000,000 (+80.00%) | Filing History |
| 2022-02-14 4:11 pm Unchanged | 2021-12-31 | 13G | AKOUOS INC AKUS | RA Capital Management, L.P. | 2,281,249 6.600% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:11 pm Unchanged | 2021-12-31 | 13G | BCLS ACQUISITION CORP BLSA | RA Capital Management, L.P. | 1,250,000 8.400% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:11 pm Unchanged | 2021-12-31 | 13G | DYNE THERAPEUTICS INC DYN | RA Capital Management, L.P. | 2,805,045 5.400% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:11 pm Unchanged | 2020-12-31 | 13G | 5:01 ACQUISITION CORP FVAM | RA Capital Management, L.P. | 750,000 8.700% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | GH RESH PLC SHS GHRS | RA Capital Management, L.P. | 2,843,757 5.500% | -135,198 (-4.54%) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | EDGEWISE THERAPEUTICS INC EWTX | RA Capital Management, L.P. | 2,613,623 5.300% | 2,613,623 (New Position) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | CONCERT PHARMACEUTICALS INC CO CNCE | RA Capital Management, L.P. | 3,510,103 9.990% | 1,686,583 (+92.49%) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | GERON CORP GERN | RA Capital Management, L.P. | 32,388,799 9.990% | 1,273,858 (+4.09%) | Filing History |